We previously reported that for locally advanced rectal cancer, post-NACRT carcinoembryonic antigen is the predominant predictor of complete pathologic response, followed by the interval between preoperative NACRT and surgery, chemotherapy regimens, clinical nodal stage, and clinical tumor stage [21]. The gene discussed is CEACAM5; the disease is neoplasm.